“Comparative Bioavailability of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) Vs. Minocycline Hydrochloride Extended Release 105-mg tablets After a Single Oral Dose: A Randomized, 3-way Crossover Study”, J of Skin, vol. 7, no. 6, p. s289, Nov. 2023, doi: 10.25251/skin.7.supp.289.